Navigation Links
Health Technology Assessment Goes Online
Date:6/15/2011

LONDON, June 15, 2011 /PRNewswire/ --


Pharma IQ is pioneering new HTA discussion platform with launch of the first ever HTA Online event - Global HTA and CER Forum, which will take an innovative form of 12 online session over the course of August.

Health Technology Assessment has recently observed an unprecedented global  expansion. Clinical and cost effectiveness are assessed for pharmaceuticals in Australia, Canada and the UK, while clinical benefit is the main focus in France and Germany for new drugs. CER is rapidly gaining momentum in the US to inform federal funding decisions, while commercial US payers use clinical and economic evidence in formulary listings.

Over 12 speakers from 10 countries, including 5 HTA agencies, will deliver 13 presentations:

• National Institute for Health and Clinical Excellence  (NICE)

• Patented Medicine Prices Review Board (PMPRB)

• Spanish Agency for Health Technology  Assessment (AETS)

• Roche Products

• GlaxoSmithKline

• HIQA

• Office of Health Economics

• F. Hoffmann-La Roche

• Amgen

Key topics to discussed by expert panel include:

  • Speeding the reimbursement processes with first-hand input from prominent HTA bodies: NICE, OHE and HIQA
  • Exploring the efforts of standardisation of HTA in Europe

  • Implementing a best practice approach to value-based pricing

  • Analysing the finer points of performance-based reimbursement and its impact

  • Aligning HTA strategies with insight from leading pharma and biotech companies:  GSK, Roche and Amgen

  • Designing product development programmes to maximise reimbursement success

The online form of the event is meant to help to reach the global audience and enable experts from Europe to have a live discussion with their colleagues in US, Canada and Australia without the need to leave their desk.

' In response to the fact that we operate in a time of reduced budgets and time, this conference takes place 100% online, therefore no travelling expenses or timing conflicts would occur' says Andrea Charles, Global HTA and CER Forum Director. 'What's more, if someone misses a session, it can always be accesses online as a recorded version of live session. It also means thatnow we can easily access global audience and industry experts from United States will be able to network easily with their colleagues from Europe without the need of leaving their desk or home'.

To find out more about how Global HTA and CER Forum plans to bring together word-wide renowned experts in the field, or to join the online discussion, visit the event website: http://www.htaforumonline.com

https://www.htaforumonline.com/?utm_campaign=PressReleasesbrochure&utm_medium=online&utm_source=Press_ReleasesBR&MAC=20511.001PR2

For more information, images or press passes, contact:

PHARMA IQ
Joanna Checinska, Marketing Manager
Email: joanna.checinska@iqpc.co.uk
Phone: +44(0)2073689300



'/>"/>
SOURCE Pharma IQ
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Monogram Biosciences to Present at the Thomas Weisel Partners Healthcare Conference 2008
2. SCAN Health Plan Offers Seniors Five Tips to Prepare for Surgery
3. Mergent, Inc. Announces Changes to the HealthShares(TM) European Drugs Index
4. Concentric Medical(R) Announces Co-Marketing Agreement With InTouch Health(R) to Advance Acute Ischemic Stroke Care
5. Mindray Medical to Attend Morgan Stanley Global Healthcare Unplugged Conference
6. BioNeutrals Ygiene(TM) New Hospital Grade Disinfectant Will Save Lives and Billions of Dollars Annually at Health Care Facilities Around the World
7. RF Technologies(R) Installs Safe Place(R) Solution for Pediatric and Infant Security at ProHealth Cares Waukesha Memorial Hospital
8. Rosetta Genomics and the National Institute of Health (NIH) to Identify Potential MicroRNA Drug Targets for HIV
9. Inc. Magazine Names Senior Whole Health the Number One Fastest-Growing Private Company in US
10. TVM Capital, Signet Healthcare Partners and Paul Capital Healthcare Enter into euro 26 Million Financing of SpePharm
11. Beckman Coulter to Present at the Thomas Weisel Healthcare Conference 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/10/2017)... ... October 10, 2017 , ... ... program has won a US2020 STEM Mentoring Award. Representatives of the FirstHand program ... in Volunteer Experience from US2020. , US2020’s mission is to change the trajectory ...
(Date:10/10/2017)... International research firm Parks Associates announced today that Tom ... 2017 Annual Meeting , October 11 in Scottsdale, Arizona ... and how smart safety and security products impact the competitive landscape. ... Parks Associates: Smart Home Devices: Main Purchase Driver ... "The residential security market has experienced continued growth, and ...
(Date:10/10/2017)... (PRWEB) , ... October 10, 2017 , ... ... innovation and business process optimization firm for the life sciences and healthcare industries, ... conference in San Francisco. , The presentation, “Automating GxP Validation for Agile ...
(Date:10/9/2017)... SAN DIEGO , Oct. 9, 2017 /PRNewswire/ ... a biological mechanism by which its ProCell stem ... of critical limb ischemia.  The Company, demonstrated that ... the amount of limbs saved as compared to ... of the molecule HGF resulted in reduction of ...
Breaking Biology Technology:
(Date:4/11/2017)... 11, 2017 Research and Markets has announced ... report to their offering. ... global eye tracking market to grow at a CAGR of 30.37% ... Tracking Market 2017-2021, has been prepared based on an in-depth market ... landscape and its growth prospects over the coming years. The report ...
(Date:4/5/2017)... April 5, 2017  The Allen Institute for Cell ... Explorer: a one-of-a-kind portal and dynamic digital window into ... data, the first application of deep learning to create ... cell lines and a growing suite of powerful tools. ... these and future publicly available resources created and shared ...
(Date:4/3/2017)... 3, 2017  Data captured by IsoCode, ... detected a statistically significant association between the ... treatment and objective response of cancer patients ... predict whether cancer patients will respond to ... well as to improve both pre-infusion potency testing ...
Breaking Biology News(10 mins):